Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.

Kidneys have long been recognized as a major source of plasminogen activators (PAs). However, neither the sites of synthesis of the enzymes nor their role in renal function have been elucidated. By the combined use of zymographies on tissue sections and in situ hybridizations, we have explored the cellular distribution of urokinase-type (u-PA) and tissue-type (t-PA) plasminogen activators and of their mRNAs in developing and adult mouse kidneys. In 17.5-d old embryos, renal tubules synthesize u-PA, while S-shaped bodies produce t-PA. In the adult kidney, u-PA is synthesized and released in urine by the epithelial cells lining the straight parts of both proximal and distal tubules. In contrast, t-PA is produced by glomerular cells and by epithelial cells lining the distal part of collecting ducts. The precise segmental distribution of PAs suggests that both enzymes may be implicated in the maintenance of tubular patency, by catalyzing extracellular proteolysis to prevent or circumvent protein precipitation.

[1]  L. Gold,et al.  Human plasma fibronectin as a substrate for human urokinase. , 1989, The Biochemical journal.

[2]  D. Belin,et al.  Plasminogen activators in the mouse mammary gland. Decreased expression during lactation. , 1989, The Journal of biological chemistry.

[3]  W. Muellbacher,et al.  Regulation of plasminogen activation in isolated perfused rat kidney. , 1989, The American journal of physiology.

[4]  T. V. van Berkel,et al.  Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells. , 1988, The Journal of biological chemistry.

[5]  N. Bang,et al.  Analysis of the plasminogen activator activity of the human glomerulus. , 1988, Kidney international.

[6]  R. Rickles,et al.  Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation. , 1988, The Journal of biological chemistry.

[7]  H. Holthöfer,et al.  Plasminogen activators during differentiation of the human kidney. , 1987, Differentiation; research in biological diversity.

[8]  D. Belin,et al.  Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface , 1987, The Journal of cell biology.

[9]  D. Belin,et al.  Amiloride selectively inhibits the urokinase‐type plasminogen activator , 1987, FEBS letters.

[10]  K. Sakakibara,et al.  Determination of urokinase in the urine of healthy volunteers and patients with renal diseases. , 1986, Thrombosis research.

[11]  D. Belin,et al.  Plasminogen activators and their inhibitors in a human mammary cell line (HBL-100). Modulation by glucocorticoids. , 1986, The Journal of biological chemistry.

[12]  D. Rijken,et al.  Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture. , 1986, Thrombosis research.

[13]  D. Belin,et al.  Plasminogen activator in mouse and rat oocytes: Induction during meiotic maturation , 1985, Cell.

[14]  R. Duvoisin,et al.  Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. , 1985, European journal of biochemistry.

[15]  D. Belin,et al.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.

[16]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[17]  D. Belin,et al.  Tumor promoter PMA stimulates the synthesis and secretion of mouse pro‐urokinase in MSV‐transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content. , 1984, The EMBO journal.

[18]  A. Vaheri,et al.  Laminin interacts with plasminogen and its tissue‐type activator , 1984, FEBS letters.

[19]  D. Belin,et al.  Concomitant secretion of prourokinase and of a plasminogen activator- specific inhibitor by cultured human monocytes-macrophages , 1984, The Journal of experimental medicine.

[20]  S. Thorsen,et al.  Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. , 1984, European journal of biochemistry.

[21]  K. Danø,et al.  Human endothelial cells contain one type of plasminogen activator , 1984, FEBS letters.

[22]  K. Danø,et al.  Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse , 1984, The Journal of cell biology.

[23]  D. Lawrence,et al.  Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Chao,et al.  Purification and characterization of rat urinary esterase A, a plasminogen activator. , 1983, The Journal of biological chemistry.

[25]  D. Belin,et al.  The production of distinct forms of plasminogen activator by mouse embryonic cells. , 1982, Developmental biology.

[26]  R. Simmer,et al.  Protease-nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cells , 1980, Cell.

[27]  J. Chao,et al.  Amiloride inhibits mammalian renal kallikrein and a kallikrein-like enzyme from toad bladder and skin. , 1980, The Journal of clinical investigation.

[28]  L. Ossowski,et al.  Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue , 1979, Cell.

[29]  A. Granelli‐Piperno,et al.  A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.

[30]  E. Reich ACTIVATION OF PLASMINOGEN: A GENERAL MECHANISM FOR PRODUCING LOCALIZED EXTRACELLULAR PROTEOLYSIS , 1978 .

[31]  J. Vassalli,et al.  Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate , 1977, Cell.

[32]  S. Strickland,et al.  Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm , 1976, Cell.

[33]  J. Unkeless,et al.  SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGES , 1974, The Journal of experimental medicine.

[34]  P. Vassalli,et al.  The pathogenetic role of the coagulation process in glomerular diseases of immunologic origin. , 1971, Advances in nephrology from the Necker Hospital.

[35]  R. Holemans,et al.  Localization of plasminogen activator in kidney tissue. , 1966, Laboratory investigation; a journal of technical methods and pathology.

[36]  A. Todd LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN TISSUES. , 1964, British medical bulletin.

[37]  A. Ladehoff The content of plasminogen activator in the human urinary tract. , 1960, Scandinavian journal of clinical and laboratory investigation.

[38]  D. R. Celander,et al.  Distribution of urokinase among the common mammals. , 1957, The American journal of physiology.

[39]  I. Bjerrehuus Fibrinolytic activity of urine. , 1952, Scandinavian journal of clinical and laboratory investigation.

[40]  J. Pilling,et al.  Fibrinolytic Activity of Normal Urine , 1947, Nature.

[41]  M. Stoppelli,et al.  Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U 937 monocytes ( cell migration / phorbol ester / proteolysis ) , 2022 .